August 15, 2022

Drs Melanie Cushion, Michael Farrell and Bruce Giffin have been named 2022 recipients of Daniel Drake Medals.

September 6, 2022

University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers published new findings on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments in the journal PLOS ONE.

September 7, 2022

University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.

September 7, 2022

GEN News highlighted recent University of Cincinnati and Cincinnati Children's Hospital Medical Center research on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments.

April 11, 2023

The University of Cincinnati's Atsuo Sasaki, PhD, is leading a multidisciplinary team that received National Institutes of Health funding to learn more about how an enzyme that was previously overlooked helps regulate lysosome and cellular function.

April 12, 2023

The University of Cincinnati's Christine Wilder, MD, spoke with the Cincinnati Enquirer about Hamilton County data that overdose deaths in 2022 dropped for the first time in six years.

May 19, 2023

The University of Cincinnati Cancer Center's Syed Ahmad, MD, is the national principal investigator for a phase 2 trial testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.

October 24, 2022

University of Cincinnati researchers presented results from the first-in-human trial of FLASH radiotherapy at the ASTRO 2022 annual meeting, with data suggesting FLASH may hold promise as a potential treatment for tough-to-kill tumors.

December 8, 2022

Physics World recognized the University of Cincinnati's first-in-human trial of FLASH radiotherapy as one of the Top 10 Breakthroughs of the Year for 2022.

February 8, 2023

Local 12 highlighted the University of Cincinnati's Andrew Waters and his research into novel treatments for pancreatic cancer.